• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Altria Enters $2.4 Billion Accelerated Share Repurchase Transactions in Connection with Closing of Offering of Anheuser-Busch InBev Stock

    3/19/24 4:15:00 PM ET
    $BUD
    $MO
    Beverages (Production/Distribution)
    Consumer Staples
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $BUD alert in real time by email

    Altria Group, Inc. (Altria) (NYSE:MO) today announces that we entered accelerated share repurchase (ASR) transactions under separate agreements with Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC on March 15, 2024, to repurchase $2.4 billion of our common stock. Under the terms of the ASR agreements, on March 19, 2024, we received an initial share delivery of approximately 85% of the shares to be repurchased, based on the closing price per share of our common stock on March 15, 2024. We expect the remainder of the shares to be delivered no later than the end of the second quarter of 2024. Under certain circumstances specified in the ASR agreements, we may be required to deliver shares or pay cash, at our option, upon settlement of the ASR agreements. The total number of shares ultimately purchased under the ASR agreements will depend upon final settlement and will be based on volume-weighted average prices of our common stock during the terms of the ASR transactions, less a discount. The ASR transactions are part of our expanded $3.4 billion share repurchase program, which we expect to complete by December 31, 2024. Share repurchases depend on marketplace conditions and other factors, and the program remains subject to the discretion of our Board of Directors.

    We also announce the closing of our sale of 35 million shares of Anheuser-Busch InBev SA/NV (ABI) (NYSE:BUD) (Euronext: ABI) (MEXBOL: ANB) (JSE: ANH) through a global secondary offering (offering) comprised of a public offering of ABI ordinary shares represented by American depositary shares (ADS) in the United States, a public offering of ABI ordinary shares in the United States, a concurrent private placement of ABI ordinary shares in the European Economic Area and the United Kingdom and an offering of ABI ordinary shares, including ABI ordinary shares represented by ADSs, in other countries outside the United States, at a price of $61.50 per ADS, corresponding to €56.17 per ABI ordinary share. In addition, ABI repurchased $200 million of ordinary shares directly from us, concurrently with the completion of the offering. We granted the underwriters an option to purchase up to an additional 5.25 million of our ABI shares at the price per ADS paid by the underwriters in the offering, exercisable within 30 days of the underwriting agreement, executed on March 14, 2024. In conjunction with the offering, we committed to a 180-day lockup from the date of the underwriting agreement with the lead underwriter for our remaining ABI shares.

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any offer or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

    Forward-Looking and Cautionary Statements

    This release contains certain forward-looking statements that are subject to various risks and uncertainties and are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, the total number of shares to be delivered at the final settlement of the ASR transactions, the expected timing of the final settlement of the ASR transactions and the expected timing of completion of our expanded share repurchase program. Factors that may cause actual results to differ include prevailing economic, market or business conditions or changes in such conditions. Other risk factors are detailed from time to time in our publicly filed reports, including our Annual Report on Form 10-K for the year ended December 31, 2023. These forward-looking statements speak only as of the date of this release. We assume no obligations to provide any revisions to, or update, any forward-looking statements contained in or implied by this release.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240319501333/en/

    Get the next $BUD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BUD
    $MO

    CompanyDatePrice TargetRatingAnalyst
    Altria Group Inc.
    $MO
    1/9/2026$63.00Neutral → Buy
    UBS
    Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
    $BUD
    11/28/2025Buy → Hold
    Deutsche Bank
    Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
    $BUD
    11/19/2025$75.00Overweight
    Wells Fargo
    Altria Group Inc.
    $MO
    7/9/2025$50.00Underperform
    Jefferies
    Altria Group Inc.
    $MO
    7/2/2025$59.00Sell → Neutral
    UBS
    Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
    $BUD
    5/12/2025$88.00Neutral → Buy
    Goldman
    Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
    $BUD
    4/2/2025Buy
    Berenberg
    Altria Group Inc.
    $MO
    4/1/2025Buy → Hold
    Deutsche Bank
    More analyst ratings

    $BUD
    $MO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Davis Robert Matthews bought $48,599 worth of shares (1,200 units at $40.50), increasing direct ownership by 16% to 8,473 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:08:44 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Clarke Ian L.T. bought $44,625 worth of shares (1,100 units at $40.57), increasing direct ownership by 18% to 7,145 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:03:21 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $BUD
    $MO
    SEC Filings

    View All

    SEC Form 6-K filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

    6-K - Anheuser-Busch InBev SA/NV (0001668717) (Filer)

    3/3/26 4:38:50 PM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form IRANNOTICE filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

    IRANNOTICE - Anheuser-Busch InBev SA/NV (0001668717) (Filer)

    3/3/26 4:05:02 PM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 20-F filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

    20-F - Anheuser-Busch InBev SA/NV (0001668717) (Filer)

    3/3/26 4:02:35 PM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    $BUD
    $MO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Altria Declares Regular Quarterly Dividend of $1.06 Per Share

    Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.06 per share, payable on April 30, 2026 to shareholders of record as of March 25, 2026. The ex-dividend date is March 25, 2026. View source version on businesswire.com: https://www.businesswire.com/news/home/20260225648687/en/ Altria Client Services Investor Relations 804-484-8222 Altria Client Services Media Relations 804-484-8897 www.altria.com/contact-us/media

    2/26/26 1:00:00 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2026 Full-Year Earnings Guidance

    Altria Group, Inc. (Altria) (NYSE:MO) is participating in the Consumer Analyst Group of New York Conference in Orlando, Florida, today. Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Executive Vice President and Chief Financial Officer, will highlight the portfolio we are building to capture the growing smoke-free opportunity, discuss how we are evolving our business and capabilities to lead the U.S. nicotine space and provide more detail on our long-term growth aspirations. Remarks and Presentation The presentation will be webcast live on www.altria.com in a listen-only mode, beginning at approximately 1:00 p.m. Eastern Time. A copy of the business pr

    2/18/26 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    AB InBev Reports Full Year and Fourth Quarter 2025 Results

    Underlying EPS increased by 6% with continued margin expansion and free cash flow generation of 11.3 billion USD Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211688662/en/Figure 14. Terms and debt repayment schedule as of 31 December 2025 (billion USD) Regulated and inside information1 "Beer plays an important role in bringing people together and creating moments of celebration. In 2025, we executed our strategy, made disciplined capital allocation choices and delivered growth within our outlook for the year, even as we navigated a dynamic consumer envir

    2/12/26 1:01:00 AM ET
    $APO
    $BUD
    Investment Managers
    Finance
    Beverages (Production/Distribution)
    Consumer Staples

    $BUD
    $MO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Altria upgraded by UBS with a new price target

    UBS upgraded Altria from Neutral to Buy and set a new price target of $63.00

    1/9/26 8:23:08 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Anheuser-Busch InBev downgraded by Deutsche Bank

    Deutsche Bank downgraded Anheuser-Busch InBev from Buy to Hold

    11/28/25 7:17:58 AM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    Wells Fargo initiated coverage on Anheuser-Busch InBev with a new price target

    Wells Fargo initiated coverage of Anheuser-Busch InBev with a rating of Overweight and set a new price target of $75.00

    11/19/25 8:56:04 AM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    $BUD
    $MO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & General Counsel Mccarter Robert A. Iii was granted 5,767 shares and covered exercise/tax liability with 4,517 shares, increasing direct ownership by 1% to 123,612 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    3/2/26 3:47:47 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Executive Officer Gifford William F. Jr. was granted 70,364 shares and covered exercise/tax liability with 61,849 shares, increasing direct ownership by 1% to 681,942 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    3/2/26 3:47:39 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    EVP & CFO Mancuso Salvatore was granted 17,166 shares and covered exercise/tax liability with 17,385 shares, decreasing direct ownership by 0.08% to 280,275 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    3/2/26 3:47:34 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $BUD
    $MO
    Financials

    Live finance-specific insights

    View All

    Altria Declares Regular Quarterly Dividend of $1.06 Per Share

    Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.06 per share, payable on April 30, 2026 to shareholders of record as of March 25, 2026. The ex-dividend date is March 25, 2026. View source version on businesswire.com: https://www.businesswire.com/news/home/20260225648687/en/ Altria Client Services Investor Relations 804-484-8222 Altria Client Services Media Relations 804-484-8897 www.altria.com/contact-us/media

    2/26/26 1:00:00 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    AB InBev Reports Full Year and Fourth Quarter 2025 Results

    Underlying EPS increased by 6% with continued margin expansion and free cash flow generation of 11.3 billion USD Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211688662/en/Figure 14. Terms and debt repayment schedule as of 31 December 2025 (billion USD) Regulated and inside information1 "Beer plays an important role in bringing people together and creating moments of celebration. In 2025, we executed our strategy, made disciplined capital allocation choices and delivered growth within our outlook for the year, even as we navigated a dynamic consumer envir

    2/12/26 1:01:00 AM ET
    $APO
    $BUD
    Investment Managers
    Finance
    Beverages (Production/Distribution)
    Consumer Staples

    Altria Reports 2025 Fourth-Quarter and Full-Year Results; Provides 2026 Earnings Guidance

    Altria Group, Inc. (NYSE:MO) today reports our 2025 fourth-quarter and full-year business results and provides our guidance for 2026 full-year adjusted diluted earnings per share (EPS). "2025 was a year of continued momentum for Altria, marked by strong financial performance, strategic progress across our smoke-free portfolio, new relationships in support of our long-term growth goals and significant cash returns to shareholders," said Billy Gifford, Altria's Chief Executive Officer. "For the full year, we grew adjusted diluted earnings per share by 4.4% and returned $8 billion to shareholders through dividends and share repurchases combined." "We expect to deliver 2026 full-year adjust

    1/29/26 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $BUD
    $MO
    Leadership Updates

    Live Leadership Updates

    View All

    Altria Group, Inc. Announces Retirement of CEO Billy Gifford and Appointment of Sal Mancuso as Successor

    Altria Group, Inc. (Altria) (NYSE:MO) announces today that Billy Gifford, Altria's Chief Executive Officer (CEO), has decided to retire, effective May 14, 2026 at the conclusion of the 2026 Annual Meeting of Shareholders (2026 Annual Meeting). Billy has had a distinguished career of over 30 years with the Altria family of companies and has served as Altria's CEO since 2020. Altria's Board of Directors (Board) has elected Salvatore (Sal) Mancuso to serve as Altria's CEO upon Billy's retirement. To facilitate a smooth transition, Billy plans to serve as a consultant to Altria upon his retirement through at least the end of 2026. Additionally, the Board elected Heather Newman to serve as Altri

    12/11/25 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    AB InBev and International Cricket Council Announce Landmark Global Partnership

    World's Leading Brewer becomes the Official Beer Partner of the ICC The International Cricket Council (ICC) announced AB InBev (Euronext: ABI) (NYSE:BUD) (MEXBOL: ANB) (JSE: ANH), the world's leading brewer, will become the Official Beer Partner for all major ICC tournaments starting in 2026. The partnership will be led by Budweiser 0.0, Budweiser's no-alcohol beer in India, with other ABI mega brands activating in Europe and Africa. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251211250826/en/AB InBev and ICC announce global partnership From attending a match live in-stadium to watching one at a bar or pub with friends, with

    12/11/25 4:31:00 AM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    Corona Cero Brings Golden Moments to the Mountains of Milano Cortina 2026

    First-ever no-alcohol beer sponsor of Olympic Winter Games celebrates "For Every Golden Moment" platform with consumers globally As the 100-day countdown to the Olympic Winter Games continues, and in a year the global Corona brand is celebrating its 100th anniversary, Corona Cero is officially set to bring golden moments to the slopes of Milano Cortina 2026. As the first no-alcohol beer sponsor of the Winter Olympics, the brand is revving up its "For Every Golden Moment" global platform to invite consumers to celebrate every golden moment any time, any season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251105994873/en/Corona

    11/5/25 4:30:00 AM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    $BUD
    $MO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

    SC 13D/A - Anheuser-Busch InBev SA/NV (0001668717) (Subject)

    10/1/24 5:20:48 PM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

    SC 13D/A - Anheuser-Busch InBev SA/NV (0001668717) (Subject)

    10/1/24 4:59:00 PM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

    SC 13D/A - Anheuser-Busch InBev SA/NV (0001668717) (Subject)

    6/21/24 4:30:51 PM ET
    $BUD
    Beverages (Production/Distribution)
    Consumer Staples